Novo Nordisk AS New Product Development Pipeline

  • August 2008
  • -
  • Global Markets Direct
  • -
  • 40 pages

The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Report Coverage

• Details of development stage by segment and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed data on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• About this Report s of novel technologies relating to new product development of the firm .
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Why Should You Get This Report?

• A single source to fulfill competitor information relating to products in development.
• Identify new product development that are potential competitor to your product lines.
Understand a firm 's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted industry ing activities.
• Take corrective measures on your own development programs and Research and Development initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and industry ing partners.
• Helps avoid patent infringement.
• Timelines from concept to industry lets you keep track of industry potential build for a new product.
Assess a firm 's future growth by determining its pipeline depth, for probable take over opportunities.

Table Of Contents

1 Table of Contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 7

II Company Snapshot 8
II. 1 Facts and Figures 8
II. 2 Company Profile 8
II. 3 Financial Performance 8
II. 4 Market Outlook - In Vitro Diagnostics 8
3 Business Overview 9
III. 1 Business Description 9
III. 2 Major Products and Services 9
III. 2.1 Overview 9

IV History 11

V Competitors 13
6 Key Executives 14

VII Key Employee Biographies 15

VIII Company Statement 17
9 Operations and Subsidiaries 20
IX. 1 Headquarter 20
IX. 2 Other Locations and Subsidiaries 20

X Recent Developments 22
X. 1 Financial Announcements 22
X. 1.1 August 07, 2008: November o Reports 1H 2008 Results 22
X. 1.2 April 30, 2008: November o Reports Q1 2008 Results 24
X. 1.3 January 31, 2008: November o Reports 2007 Results 26
X. 1.4 October 31, 2007: November o December lares Nine Months Ended 2007 Results 28
X. 1.5 August 03, 2007: November o Reports H1 2007 Results 29
X. 1.6 May 02, 2007: November o Reports Q1 2007 Results 30
X. 1.7 January 31, 2007: November o Reports 2006 Results 31
X. 2 Product News 32
X. 2.1 September 11, 2001: InDuo Is Launched To Help Improve Diabetes Management 32

XI November o Nordisk A/S Pipeline Products 33
XI. 1 November o Nordisk A/S Product Pipeline Analysis 33
XI. 1.1 November o Nordisk A/S Pipeline Products By Equipment Type 33
XI. 1.2 November o Nordisk A/S Pipeline Products By Development Stage 34
XI. 1.3 November o Nordisk A/S Pipeline Products By Therapy Area 35
XI. 2 Future Inhalation Systems 35
XI. 2.1 Product Description 35
XI. 2.2 Product Status 35
XI. 3 Future Insulin Infusion Systems 35
XI. 3.1 Product Description 35
XI. 3.2 Product Status 36
XI. 4 Next Generation Durable Pen 36
XI. 4.1 Product Description 36
XI. 4.2 Product Status 36
XI. 5 Next Generation Needles 36
XI. 5.1 Product Description 36
XI. 5.2 Product Status 37

XII Appendix 38
XII. 1 Methodology 38
XII. 1.1 Coverage 38
XII. 1.2 Secondary Research 39
XII. 1.3 Primary Research 39
XII. 1.4 Expert Panel Validation 40
XII. 2 Contact Us 40
XII. 3 About World March kets Direct 40
XII. 4 Disclaimer 40



I. 1 List of Data tables
Data table 1: November o Nordisk A/S,Key Facts 8
Data table 2: November o Nordisk A/S, Key Executives , 14
Data table 3: November o Nordisk A/S, Other Locations 20
Data table 4: November o Nordisk A/S, Subsidiaries 20
Data table 5: November o Nordisk A/S Pipeline Products by Equipment Type 33
Data table 6: November o Nordisk A/S Pipeline Products By Development Stage 34
Data table 7: November o Nordisk A/S Pipeline Products By Therapy Area 35



I. 2 List of Charts
Chart 1: November o Nordisk A/S Pipeline Products By Development Stage 34
Chart 2: World March kets Direct Methodology 38

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

GE: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

GE: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

  • $ 2 450
  • Company report
  • August 2014
  • by Venture Planning Group

The strategic assessment of GE, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation ...

Philips: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

Philips: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

  • $ 2 450
  • Company report
  • August 2014
  • by Venture Planning Group

The strategic assessment of Philips, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation ...

Shimadzu: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

Shimadzu: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

  • $ 2 450
  • Company report
  • August 2014
  • by Venture Planning Group

The strategic assessment of Shimadzu, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.